In response to the COVID-19 pandemic, there have been significant shifts in recommendations for managing patients breathing through a tracheostoma. These recommendations include limiting or eliminating any aerosol generating procedure (AGP) with the goal to protect both patients and health care providers during this crisis. AGPs include any procedure which elicits a cough or causes droplets or aerosolized particles to spread. This has major implications for patients breathing through a tracheostoma as well as the HCPs who care for them. These recommendations impact direct care of patients with a total laryngectomy or tracheostomy.
Prof Dr Michiel van den Brekel, MD, PhD
Head and Neck Surgeon, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Dr Mario Fernandez, MD, PhD
Head and Neck Surgeon, Hospital General Universitario “Gregorio Marañón”, Madrid, Spain
Mr James Kelley, BSc Physiotherapy, MSc Critical Care
Chartered Physiotherapist, Head of Acute Services, The Wellington Hospital, London, United Kingdom
Dr Bernard Fikkers, MD, PhD
Intensivist, Radboud University Medical Center, Nijmegen, the Netherlands
Prof Dr Alberto Deganello, MD, PhD
Head and Neck Surgeon, University of Brescia, Spedali Civili di Brescia, Brescia, Italy
Prof Dr Andreas Dietz, MD, PhD
Head and Neck Surgeon, University Hospital Leipzig, Leipzig, Germany
Share
Save to my content